May 30, 2012 — Tryton Medical Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced results of a patient-level pooled analysis of six-month clinical outcomes of the Tryton Side Branch Stent. Findings were presented last week in Paris at EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions.

May 30, 2012 - According to study results to be featured in the late-breaking clinical trials session at the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress in Philadelphia, the Resolute drug-eluting stent (DES) from Medtronic Inc. yields strong performance in coronary artery disease (CAD) patients both with and without diabetes through two years of follow-up.

May 30, 2012— Boston Scientific Corp. announces the U.S. Food and Drug Administration has cleared an expanded use indication for the CRE Wireguided Balloon Dilator for endoscopic dilation of the Sphincter of Oddi following sphincterotomy.  The new indication offers physicians the ability to now perform Dilation Assisted Stone Extraction (DASE) with the CRE Wireguided Balloon Dilator.  This is an alternative method for the removal of difficult stones in the biliary duct.

May 30, 2012 — Leroy Chiao, Ph.D., a former NASA astronaut, will share his experiences in performing and transmitting echocardiograms from outer space during a special presentation during the American Society of Echocardiography’s (ASE) 23rd Annual Scientific Sessions in National Harbor, Md., June 30-July 3. The session, “Hearts in Space”, planned for July 3 from 12:00-1:15 p.m., will give attendees insight into the medical aspects of the U.S. space program as well as the short- and long-term impact of weightlessness on cardiovascular function. The session will inform attendee’s clinical practice by relating remote diagnosis from space to terrestrial telemedicine.

May 30, 2012 — MAQUET Cardiopulmonary, a business unit of MAQUET Cardiovascular and a leader in extracorporeal membrane oxygenation (ECMO) and extracorporeal life support (ECLS) systems, announced that it has signed an agreement with Avalon Laboratories to acquire its Avalon Elite Bi-Caval Dual Lumen Catheter and complimentary vascular access kits for use during ECMO and ECLS.

May 30, 2012 — At the European Stroke Conference in Lisbon, Portugal, Stryker announced the results of the TREVO 2 clinical trial. The study met the primary effectiveness endpoint, with the Trevo Retriever achieving significantly better post-device revascularization than the Merci Retriever (86.4 percent in the Trevo Retriever arm compared to 60 percent in the Merci Retriever arm).

 


The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology (EP) meeting in the world, Heart Rhythm Society (HRS) 2012 in May, held in Boston. Several new advances were showcased that may have a major impact on the future of EP.

 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now